ARTICLE | Company News
FDA approves Axiron
November 24, 2010 11:00 PM UTC
FDA approved an NDA from Acrux Ltd. (ASX:ACR) for Axiron testosterone as replacement therapy in men for conditions associated with a deficiency or absence of testosterone, including primary and hypogo...